Please login to the form below

Not currently logged in
Email:
Password:

Bayer: Asia will account for €11bn of sales by 2015

Company says half of its sales in Asia will come from China

Bayer has outlined an ambitious set of targets for its Asia business that include increasing its sales in the region by 60 per cent to €11bn within the next four years.

The group, which operates across healthcare, materials and crop sciences, anticipates that China will play a key role in achieving these targets.

Greater China is planned to account for some €6bn within the next four years, overshadowing the region's other key emerging market India, where Bayer hopes to double its sales to €1bn by 2015.

Twenty years ago Asia accounted for 10 per cent, or just over €2bn of Bayer's sales, last year the region was worth €6bn or 20 per cent of the group's sales.

Speaking at a press conference in Shanghai today, management board chairman Dr Marijn Dekkers was keen to talk up Bayer's local roots in Asia.

“We have been operating for more than a century in China, India and Japan,” he said. “We are familiar with the markets, and we know how to tune our approaches to the different conditions prevailing in different markets in order to further expand our business.”

Bayer's healthcare operations place it in the top companies in the sector in China. Last year its health sales reached €926m, but Bayer wants to see these reach €2.5bn by 2015.

To help meet its group targets, Bayer will expand its production and distribution network across the region.

The company also plans to boost its R&D presence in the area, focusing on collaborations with the leading institutes and centres of expertise, and integrating Asian patients into the early stages of global development programmes.

Bayer also plans to submit innovative medicines for registration concurrently in Asia, Europe and the US.

As part of its plans Bayer will also increase its Asian workforce. This grew by 8 per cent in the past 12 months and could rise from 23,700 in 2010 to more than 30,000 by 2015, according to Dekkers.

 

Related links

Country Report: China
Country Report: India

16th November 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....